Mitochondrial membrane permeabilization in neuronal injury

Nature Reviews Neuroscience

Volumn 10, Issue 7, 2009, Pages 481-494

  Galluzzi, Lorenzo ^a,b   Blomgren, Klas ^c,d   Kroemer, Guido ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALPAIN; CASPASE; CHAPERONE; CREATINE; CYCLOPHILIN D; CYCLOSPORIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; LITHIUM; MITOCHONDRIAL CREATINE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NELFINAVIR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NUCLEASE; PHOSPHATASE; PIFITHRIN ALPHA; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; RECOMBINANT X LINKED INHIBITOR OF APOPTOSIS PROTEIN; RITONAVIR; TENSIN; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CELL DEATH; CELL LOSS; CELL SURVIVAL; DRUG DESIGN; DRUG MECHANISM; DRUG MEGADOSE; EXCITOTOXICITY; LOW DRUG DOSE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY BURST; RESPIRATORY CHAIN; REVIEW; RODENT; SIGNAL TRANSDUCTION; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; APOPTOSIS; ELECTRON TRANSPORT; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR CHAPERONES; NECROSIS; NEURONS; OXIDATION-REDUCTION; PEPTIDE HYDROLASES; PERMEABILITY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 67649460932     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2665     Document Type: Review

References (187)

1. Rossi, D. J., Brady, J. D. & Mohr, C. Astrocyte metabolism and signaling during brain ischemia. Nature Neurosci. 10, 1377-1386 (2007).
2. Mattson, M. P. & Kroemer, G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 9, 196-205 (2003).
3. Kroemer, G. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3-11 (2009). This article provides up-to-date guidelines for the use of cell death-related terminology in scientific publications, as provided by the Nomenclature Committee on Cell Death, an organization constituted by reputed researchers in the field of cell death worldwide.
4. Wajant, H. The Fas signaling pathway: more than a paradigm. Science 296, 1635-1636 (2002).
5. Bredesen, D. E., Mehlen, P. & Rabizadeh, S. Receptors that mediate cellular dependence. Cell Death Differ. 12, 1031-1043 (2005).
6. Kroemer, G., Galluzzi, L. & Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163 (2007). This review provides a comprehensive analysis of the mitochondrial pathway of cell death and of its multifaceted implications for human physiology and pathology.
7. Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795 (2006).
8. Miyawaki, T. et al. Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons. Proc. Natl Acad. Sci. USA 105, 4892-4897 (2008).
9. Legos, J. J. et al. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res. 892, 70-77 (2001).
10. Xu, Z. et al. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sci. 79, 1895-1905 (2006).
11. Kikuchi, M., Tenneti, L. & Lipton, S. A. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J. Neurosci. 20, 5037-5044 (2000).
12. Mori, T. et al. Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J. Cereb. Blood Flow Metab. 22, 444-452 (2002).
13. Namura, S. et al. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl Acad. Sci. USA 98, 11569-11574 (2001).
14. Chiang, C. W. et al. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 97, 1289-1297 (2001).
15. Xin, M. & Deng, X. Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation. J. Biol. Chem. 281, 18859-18867 (2006).
16. Santoro, M. F. et al. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J. Biol. Chem. 273, 13119-13128 (1998).
17. Sasaki, T. et al. Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model. Brain Res. 1108, 98-106 (2006).
18. Ho, Y., Logue, E., Callaway, C. W. & DeFranco, D. B. Different mechanisms account for extracellular-signal regulated kinase activation in distinct brain regions following global ischemia and reperfusion. Neuroscience 145, 248-255 (2007).
19. Zhang, Q. G., Wu, D. N., Han, D. & Zhang, G. Y. Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett. 581, 495-505 (2007).
20. Gao, Y. et al. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosissignaling pathway. J. Cereb. Blood Flow Metab. 25, 694-712 (2005).
21. Guan, Q. H., Pei, D. S., Zong, Y. Y., Xu, T. L. & Zhang, G. Y. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 139, 609-627 (2006).
22. Pirianov, G. et al. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. J. Cereb. Blood Flow Metab. 27, 1022-1032 (2007).
23. Kuan, C. Y. et al. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl Acad. Sci. USA 100, 15184-15189 (2003).
24. Brecht, S. et al. Specific pathophysiological functions of JNK isoforms in the brain. Eur. J. Neurosci. 21, 363-377 (2005).
25. Jin, H. O. et al. Up-regulation of Bak and Bim via JNK downstream pathway in the response to nitric oxide in human glioblastoma cells. J. Cell Physiol. 206, 477-486 (2006).
26. Lei, K. & Davis, R. J. JNK phosphorylation of Bimrelated members of the Bcl2 family induces Baxdependent apoptosis. Proc. Natl Acad. Sci. USA 100, 2432-2437 (2003).
27. Wang, Q., Zhang, Q. G., Wu, D. N., Yin, X. H. & Zhang, G. Y. Neuroprotection of selenite against ischemic brain injury through negatively regulating early activation of ASK1/JNK cascade via activation of PI3K/AKT pathway. Acta Pharmacol. Sin. 28, 19-27 (2007).
28. Zhang, F., Phiel, C. J., Spece, L., Gurvich, N. & Klein, P. S. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J. Biol. Chem. 278, 33067-33077 (2003).
29. Dill, J., Wang, H., Zhou, F. & Li, S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci. 28, 8914-8928 (2008).
30. Luo, J. M. et al. PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. Eur. J. Neurosci. 26, 828-842 (2007).
31. Choi, J. S. et al. Phosphorylation of PTEN and Akt in astrocytes of the rat hippocampus following transient forebrain ischemia. Cell Tissue Res. 319, 359-366 (2005).
32. Moncada, S. & Bolanos, J. P. Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97, 1676-1689 (2006).
33. Vieira, H. & Kroemer, G. Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life 55, 613-616 (2003).
34. Higuchi, Y., Hattori, H., Hattori, R. & Furusho, K. Increased neurons containing neuronal nitric oxide synthase in the brain of a hypoxic-ischemic neonatal rat model. Brain Dev. 18, 369-375 (1996).
35. Matrone, C. et al. HIF-1a reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J. Neurochem. 90, 368-378 (2004).
36. Vieira, H. L. et al. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305-4316 (2001).
37. Zhu, C. et al. Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia-ischaemia. J. Neurochem. 90, 462-471 (2004).
38. Cho, D. H. et al. S-nitrosylation of Drp1 mediates b-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105 (2009).
39. Elibol, B. et al. Nitric oxide is involved in ischemiainduced apoptosis in brain: a study in neuronal nitric oxide synthase null mice. Neuroscience 105, 79-86 (2001).
40. Zhao, X., Haensel, C., Araki, E., Ross, M. E. & Iadecola, C. Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase. Brain Res. 872, 215-218 (2000).
41. Iadecola, C., Zhang, F. & Xu, X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268, R286-R292 (1995).
42. Martinez-Murillo, R. et al. The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model. Neurosci. Lett. 415, 149-153 (2007).
43. Pei, D. S. et al. Exogenous nitric oxide negatively regulates c-Jun N-terminal kinase activation via inhibiting endogenous NO-induced S-nitrosylation during cerebral ischemia and reperfusion in rat hippocampus. J. Neurochem. 106, 1952-1963 (2008).
44. Khan, M. et al. Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15, 114-124 (2006).
45. Zhu, D. Y., Liu, S. H., Sun, H. S. & Lu, Y. M. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J. Neurosci. 23, 223-229 (2003).
46. Kondo, T. et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17, 4180-4189 (1997).
47. Xiong, Y., Shie, F. S., Zhang, J., Lee, C. P. & Ho, Y. S. Prevention of mitochondrial dysfunction in posttraumatic mouse brain by superoxide dismutase. J. Neurochem. 95, 732-744 (2005).
48. Kim, G. W., Kondo, T., Noshita, N. & Chan, P. H. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 33, 809-815 (2002).
49. Crack, P. J. et al. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J. Neurochem. 78, 1389-1399 (2001).
50. Saito, A., Hayashi, T., Okuno, S., Ferrand-Drake, M. & Chan, P. H. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J. Neurosci. 23, 1710-1718 (2003).
51. Ishibashi, N., Prokopenko, O., Weisbrot-Lefkowitz, M., Reuhl, K. R. & Mirochnitchenko, O. Glutathione peroxidase inhibits cell death and glial activation following experimental stroke. Brain Res. Mol. Brain Res. 109, 34-44 (2002).
52. Takagi, Y. et al. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl Acad. Sci. USA 96, 4131-4136 (1999).
53. Saito, A., Hayashi, T., Okuno, S., Nishi, T. & Chan, P. H. Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1. Brain Res. Mol. Brain Res. 127, 89-95 (2004).
54. Yu, F., Sugawara, T., Nishi, T., Liu, J. & Chan, P. H. Overexpression of SOD1 in transgenic rats attenuates nuclear translocation of endonuclease G and apoptosis after spinal cord injury. J. Neurotrauma 23, 595-603 (2006).
55. Slemmer, J. E., Shacka, J. J., Sweeney, M. I. & Weber, J. T. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 15, 404-414 (2008).
56. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebocontrolled, double-blind study at multicenters. Cerebrovasc. Dis. 15, 222-229 (2003).
57. Watanabe, T., Tahara, M. & Todo, S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc. Ther. 26, 101-114 (2008).
58. Rong, Y. & Distelhorst, C. W. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu. Rev. Physiol. 70, 73-91 (2008).
59. Zhao, H., Yenari, M. A., Cheng, D., Sapolsky, R. M. & Steinberg, G. K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J. Neurochem. 85, 1026-1036 (2003).
60. Wiessner, C. et al. Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neurosci. Lett. 268, 119-122 (1999).
61. Kilic, E., Dietz, G. P., Hermann, D. M. & Bahr, M. Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52, 617-622 (2002).
62. Bonanni, L. et al. Zinc-dependent multi-conductance channel activity in mitochondria isolated from ischemic brain. J. Neurosci. 26, 6851-6862 (2006).
63. Shimizu, S., Konishi, A., Kodama, T. & Tsujimoto, Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl Acad. Sci. USA 97, 3100-3105 (2000).
64. Hisatomi, T. et al. HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J. Clin. Invest. 118, 2025-2038 (2008). This article investigated the relative contribution of caspase-dependent and caspase-independent effector mechanisms to the demise of rat photoreceptor cells induced by retinal detachment and proves that neuroprotection can be obtained by inhibiting the post-mitochondrial phases of cell death.
65. Gibson, M. E. et al. BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Mol. Med. 7, 644-655 (2001).
66. Tehranian, R. et al. Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury. J. Neurotrauma 25, 755-767 (2008).
67. Rodrigues, C. M. et al. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Natl Acad. Sci. USA 100, 6087-6092 (2003).
68. Hetz, C. et al. Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia. J. Biol. Chem. 280, 42960-42970 (2005).
69. Plesnila, N. et al. BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia. Proc. Natl Acad. Sci. USA 98, 15318-15323 (2001).
70. Ness, J. M. et al. Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res. 1099, 150-159 (2006).
71. Wingrave, J. M. et al. Higher calpastatin levels correlate with resistance to calpain-mediated proteolysis and neuronal apoptosis in juvenile rats after spinal cord injury. J. Neurotrauma 21, 1240-1254 (2004).
72. Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658 (2005).
73. Galluzzi, L. & Kroemer, G. Necroptosis: a specialized pathway of programmed necrosis. Cell 135, 1161-1163 (2008).
74. Matsumoto, S., Friberg, H., Ferrand-Drake, M. & Wieloch, T. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 19, 736-741 (1999).
75. Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662 (2005).
76. Schinzel, A. C. et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl Acad. Sci. USA 102, 12005-12010 (2005). References 72, 75 and 76 provided unequivocal evidence that CYPD regulates MPT and participates in the ischaemic response of the CNS.
77. Wang, X. et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J. Neurosci. 29, 2588-2596 (2009).
78. Cesar Mde, C. & Wilson, J. E. All three isoforms of the voltage-dependent anion channel (VDAC1, VDAC2, and VDAC3) are present in mitochondria from bovine, rabbit, and rat brain. Arch. Biochem. Biophys. 422, 191-196 (2004).
79. Tajeddine, N. et al. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 27, 4221-4232 (2008).
80. Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J. & Molkentin, J. D. Voltage-dependent anion channels are dispensable for mitochondrial- dependent cell death. Nature Cell Biol. 9, 550-555 (2007). In this work, cells isolated from Vdac1;Vdac3 double-knockout mice were subjected to small interfering RNA-mediated downregulation of VDAC2 and treated with several MMP-triggering agents, including selective inducers of MPT and MOMP. The data indicated that VDACs are dispensable for both MPT- and MOMP-driven cell death.
81. Kokoszka, J. E. et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427, 461-465 (2004).
82. Rodic, N. et al. DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells 23, 1314-1323 (2005).
83. Weaver, J. G. et al. Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. J. Clin. Invest. 115, 1828-1838 (2005).
84. Gray, S. M. et al. Hexokinase binding in ischemic and reperfused piglet brain. Biochem. Med. Metab. Biol. 53, 145-148 (1994).
85. Vannucci, R. C., Brucklacher, R. M. & Vannucci, S. J. Glycolysis and perinatal hypoxic-ischemic brain damage. Dev. Neurosci. 27, 185-190 (2005).
86. Pastorino, J. G. & Hoek, J. B. Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr. 40, 171-182 (2008).
87. Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E. & Shoshan-Barmatz, V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J. Biol. Chem. 283, 13482-13490 (2008).
88. Schlattner, U., Tokarska-Schlattner, M. & Wallimann, T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 1762, 164-180 (2006).
89. Hausmann, O. N., Fouad, K., Wallimann, T. & Schwab, M. E. Protective effects of oral creatine supplementation on spinal cord injury in rats. Spinal Cord 40, 449-456 (2002).
90. Di-Pietro, P. B. et al. Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration. Neurosci. Lett. 434, 139-143 (2008).
91. Saraste, M. Oxidative phosphorylation at the fin de siecle. Science 283, 1488-1493 (1999).
92. Lesnefsky, E. J. et al. Blockade of electron transport during ischemia protects cardiac mitochondria. J. Biol. Chem. 279, 47961-47967 (2004).
93. Chandrasekaran, K. et al. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicityinduced neuronal death. Pharmacopsychiatry 3. (Suppl. 1), 89-94 (2003).
94. Wiegand, F. et al. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 1229-1237 (1999).
95. Andrews, Z. B., Diano, S. & Horvath, T. L. Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nature Rev. Neurosci. 6, 829-840 (2005).
96. Nakase, T., Yoshida, Y. & Nagata, K. Amplified expression of uncoupling proteins in human brain ischemic lesions. Neuropathology 27, 442-447 (2007).
97. Mattiasson, G. et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nature Med. 9, 1062-1068 (2003).
98. de Bilbao, F. et al. Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels. J. Neurochem. 89, 1283-1292 (2004).
99. Yu, J. & Zhang, L. The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331, 851-858 (2005).
100. Moll, U. M., Wolff, S., Speidel, D. & Deppert, W. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17, 631-636 (2005).
101. Galluzzi, L., Morselli, E., Kepp, O., Tajeddine, N. & Kroemer, G. Targeting p53 to mitochondria for cancer therapy. Cell Cycle 7, 1949-1955 (2008).
102. Endo, H., Kamada, H., Nito, C., Nishi, T. & Chan, P. H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 26, 7974-7983 (2006).
103. Chung, Y. H. et al. Enhanced expression of p53 in reactive astrocytes following transient focal ischemia. Neurol. Res. 24, 324-328 (2002).
104. Culmsee, C. et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid b-peptide. J. Neurochem. 77, 220-228 (2001).
105. Leker, R. R., Aharonowiz, M., Greig, N. H. & Ovadia, H. The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin a. Exp. Neurol. 187, 478-486 (2004).
106. Yonekura, I., Takai, K., Asai, A., Kawahara, N. & Kirino, T. p53 potentiates hippocampal neuronal death caused by global ischemia. J. Cereb. Blood Flow Metab. 26, 1332-1340 (2006).
107. Morrison, R. S. et al. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16, 1337-1345 (1996).
108. Tasdemir, E. et al. Regulation of autophagy by cytoplasmic p53. Nature Cell Biol. 10, 676-687 (2008).
109. Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O. & Klionsky, D. J. Potential therapeutic applications of autophagy. Nature Rev. Drug Discov. 6, 304-312 (2007).
110. Maeda, K., Hata, R., Gillardon, F. & Hossmann, K. A. Aggravation of brain injury after transient focal ischemia in p53-deficient mice. Brain Res. Mol. Brain Res. 88, 54-61 (2001).
111. Matoba, S. et al. p53 regulates mitochondrial respiration. Science 312, 1650-1653 (2006). This paper provided the first demonstration that the absence of a single p53 target gene, SCO2, can recapitulate the metabolic alterations typical of cancer cells, known as the Warburg effect.
112. Zhu, C. et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxiaischemia. Cell Death Differ. 12, 162-176 (2005).
113. Garrido, C. et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13, 1423-1433 (2006).
114. Galluzzi, L., Morselli, E., Kepp, O. & Kroemer, G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim. Biophys. Acta 1787, 402-413 (2009).
115. Yang, Q. H., Church-Hajduk, R., Ren, J., Newton, M. L. & Du, C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev. 17, 1487-1496 (2003).
116. Vande Walle, L. et al. Proteome-wide identification of HtrA2/Omi substrates. J. Proteome Res. 6, 1006-1015 (2007).
117. Galluzzi, L. et al. No death without life: vital functions of apoptotic effectors. Cell Death Differ. 15, 1113-1123 (2008).
118. Mouw, G. et al. Caspase-9 inhibition after focal cerebral ischemia improves outcome following reversible focal ischemia. Metab. Brain Dis. 17, 143-151 (2002).
119. Jin, K. et al. Two caspase-2 transcripts are expressed in rat hippocampus after global cerebral ischemia. J. Neurochem. 81, 25-35 (2002).
120. Kermer, P. et al. Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res. Mol. Brain Res. 85, 144-150 (2000).
121. Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372 (1996). This is the first report on the generation and phenotypical characterization of Casp3-/- mice. Caspase 3 deficiency resulted in profound alterations of the CNS, which demonstrated that caspase 3-dependent cell death has a crucial role during mammalian CNS development.
122. Houde, C. et al. Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice. J. Neurosci. 24, 9977-9984 (2004).
123. Le, D. A. et al. Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl Acad. Sci. USA 99, 15188-15193 (2002). In this study, the small fraction of Casp3-/- mice that survived into adulthood were subjected to transient focal cerebral ischaemia. The findings supported the idea that caspase 3 and caspase 8 participate in ischaemic cell death of cortical neurons in vivo.
124. West, T., Atzeva, M. & Holtzman, D. M. Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiol. Dis. 22, 523-537 (2006).
125. Kuida, K. et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325-337 (1998). In this study, Casp9-/- mice showed a markedly enlarged and malformed cerebrum, similarly to Casp3-/- mice, which strongly corroborated the idea that the pro-apoptotic function of the apoptosome is indispensable for normal CNS development in mammals.
126. Yoshida, H. et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94, 739-750 (1998). Apaf1-/- mice were generated and characterized for their phenotypical manifestations. This study provided the first demonstration that APAF1 is required for the normal development of the mammalian brain.
127. Hao, Z. et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 121, 579-591 (2005). This study reports the generation of homozygous knock-in mice that express a CYT C variant that does not activate the apoptosome but retains normal electron transfer functions (KA allele). KA/KA mice showed extensive CNS abnormalities and embryonic or perinatal lethality.
128. Kanungo, A. K., Hao, Z., Elia, A. J., Mak, T. W. & Henderson, J. T. Inhibition of apoptosome activation protects injured motor neurons from cell death. J. Biol. Chem. 283, 22105-22112 (2008).
129. Honarpour, N., Gilbert, S. L., Lahn, B. T., Wang, X. & Herz, J. Apaf-1 deficiency and neural tube closure defects are found in fog mice. Proc. Natl Acad. Sci. USA 98, 9683-9687 (2001). Allelic complementation, western blot analyses and caspase-activation assays were performed to characterize the molecular defects of Fog mice, which turned out to be caused by a reduction in APAF1 activity.
130. Zermati, Y. et al. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol. Cell 28, 624-637 (2007).
131. Mondragon, L. et al. A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis 14, 182-190 (2009).
132. Clark, R. S. et al. boc-Aspartyl(OMe)- fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 27, 316-326 (2007).
133. Li, M. et al. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience 99, 333-342 (2000).
134. Han, B. H. et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J. Biol. Chem. 277, 30128-30136 (2002).
135. Hara, H. et al. Inhibition of interleukin 1b converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad. Sci. USA 94, 2007-2012 (1997).
136. Zhu, C. et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 14, 775-784 (2007).
137. Gill, R. et al. Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J. Cereb. Blood Flow Metab. 22, 420-430 (2002).
138. Verhagen, A. M., Coulson, E. J. & Vaux, D. L. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol. 2, REVIEWS3009 (2001).
139. Wang, X. et al. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol. Dis. 16, 179-189 (2004).
140. Saito, A., Hayashi, T., Okuno, S., Nishi, T. & Chan, P. H. Oxidative stress is associated with XIAP and Smac/ DIABLO signaling pathways in mouse brains after transient focal cerebral ischemia. Stroke 35, 1443-1448 (2004).
141. Martins, L. M. et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell Biol. 24, 9848-9862 (2004).
142. Okada, H. et al. Generation and characterization of Smac/DIABLO-deficient mice. Mol. Cell Biol. 22, 3509-3517 (2002).
143. Kugler, S. et al. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ. 7, 815-824 (2000).
144. Xu, D. G. et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med. 3, 997-1004 (1997). This study demonstrated for the first time that the elevation of NAIP levels in neurons (following the administration of a bacterial alkaloid or the intracerebral injection of a NAIP-overexpressing adenoviral vector) confers neuroprotection against ischaemic damage in vivo.
145. Perrelet, D. et al. IAP family proteins delay motoneuron cell death in vivo. Eur. J. Neurosci. 12, 2059-2067 (2000).
146. Fan, Y. F., Lu, C. Z., Xie, J., Zhao, Y. X. & Yang, G. Y. Apoptosis inhibition in ischemic brain by intraperitoneal PTD-BIR3-RING (XIAP). Neurochem. Int. 48, 50-59 (2006). This paper provides the proof-of-principle demonstration that neurons can be efficiently transduced by intraperitoneally administered chimeric polypeptides that include a membranetranslocation domain. In this case an XIAP-derived peptide resulted in limited caspase activation and DNA fragmentation and improved neurological outcomes after transient ischaemia.
147. Lotocki, G., Alonso, O. F., Frydel, B., Dietrich, W. D. & Keane, R. W. Monoubiquitination and cellular distribution of XIAP in neurons after traumatic brain injury. J. Cereb. Blood Flow Metab. 23, 1129-1136 (2003).
148. Tamura, M. et al. Targeted expression of antiapoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury. Glia 51, 312-321 (2005).
149. Vahsen, N. et al. AIF deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679-4689 (2004).
150. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001). In this work, the gene that encodes AIF (Aifm1) was ablated by homologous recombination in mouse embryonic stem cells, which were then injected into wild-type blastocysts. This study proved that AIF is essential for the early steps of embryonic development in mammals.
151. Klein, J. A. et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419, 367-374 (2002).
152. Culmsee, C. et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J. Neurosci. 25, 10262-10272 (2005).
153. Cheung, E. C. et al. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAXdependent and BAX-independent mechanisms. J. Neurosci. 25, 1324-1334 (2005).
154. Slemmer, J. E. et al. Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am. J. Pathol. 173, 1795-1805 (2008). By means of a combined experimental strategy based on in vitro and in vivo models for the traumatic cell death of neurons, AIF-specific small interfering RNAs and Hq mice, this study provided the first conclusive demonstration that AIF mediates caspase-independent cell death following traumatic brain injury.
155. Zhu, C. et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J. Exp. Med. 204, 1741-1748 (2007). This paper provided the first demonstration that AIF fails to relocalize to the nuclei of CYPA-deficient neurons (and that, conversely, CYPA nuclear translocation is impaired in the brain of Hq mice) following an ischaemic insult, in vivo.
156. David, K. K., Sasaki, M., Yu, S. W., Dawson, T. M. & Dawson, V. L. EndoG is dispensable in embryogenesis and apoptosis. Cell Death Differ. 13, 1147-1155 (2006).
157. Apostolov, E. O., Wang, X., Shah, S. V. & Basnakian, A. G. Role of EndoG in development and cell injury. Cell Death Differ. 14, 1971-1974 (2007).
158. Yamashita, D., Miller, J. M., Jiang, H. Y., Minami, S. B. & Schacht, J. AIF and EndoG in noise-induced hearing loss. Neuroreport 15, 2719-2722 (2004).
159. Lee, B. I., Lee, D. J., Cho, K. J. & Kim, G. W. Early nuclear translocation of endonuclease G and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Neurosci. Lett. 386, 23-27 (2005).
160. Wagstaff, M. J. et al. Focal cerebral ischaemia increases the levels of several classes of heat shock proteins and their corresponding mRNAs. Brain Res. Mol. Brain Res. 42, 236-244 (1996).
161. Giffard, R. G. et al. Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J. Exp. Biol. 207, 3213-3220 (2004).
162. Xu, L. et al. Chaperonin GroEL and its mutant D87K protect from ischemia in vivo and in vitro. Neurobiol. Aging 27, 562-569 (2006).
163. Yenari, M. A. et al. Antiapoptotic and antiinflammatory mechanisms of heat-shock protein protection. Ann. NY Acad. Sci. 1053, 74-83 (2005).
164. Saleh, A., Srinivasula, S. M., Balkir, L., Robbins, P. D. & Alnemri, E. S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nature Cell
165. Ruchalski, K. et al. Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J. Biol. Chem. 281, 7873-7880 (2006).
166. Gurbuxani, S. et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene 22, 6669-6678 (2003).
167. Kalinowska, M., Garncarz, W., Pietrowska, M., Garrard, W. T. & Widlak, P. Regulation of the human apoptotic DNase/RNase endonuclease G: involvement of Hsp70 and ATP. Apoptosis 10, 821-830 (2005).
168. Badin, R. A. et al. Neuroprotective effects of virally delivered HSPs in experimental stroke. J. Cereb. Blood Flow Metab. 26, 371-381 (2006).
169. Hwang, I. K. et al. Changes in immunoreactivity of HSP60 and its neuroprotective effects in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. 208, 247-256 (2007).
170. Matsumori, Y. et al. Reduction of caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke 37, 507-512 (2006).
171. Kelly, S. et al. Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann. Neurol. 52, 160-167 (2002).
172. Lee, S. H. et al. Effects of Hsp70.1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke 35, 2195-2199 (2004).
173. Choi, S. et al. Expression of Cu/Zn SOD protein is suppressed in hsp 70.1 knockout mice. J. Biochem. Mol. Biol. 38, 111-114 (2005).
174. McLaughlin, B. et al. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl Acad. Sci. USA 100, 715-720 (2003).
175. Suzuki, K., Hata, S., Kawabata, Y. & Sorimachi, H. Structure, activation, and biology of calpain. Diabetes 53 (Suppl. 1), 12-18 (2004).
176. Bevers, M. B. & Neumar, R. W. Mechanistic role of calpains in postischemic neurodegeneration. J. Cereb. Blood Flow Metab. 28, 655-673 (2008).
177. Blomgren, K. et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxiaischemia: a mechanism of "pathological apoptosis"? J. Biol. Chem. 276, 10191-10198 (2001).
178. Cao, G. et al. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J. Neurosci. 27, 9278-9293 (2007). This work focused on the molecular pathways underlying the mitochondrio-nuclear translocation of AIF in neurons and was the first study that attributed a crucial role to calpain I in the ischaemia-induced mitochondrial release of AIF.
179. Higuchi, M. et al. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280, 15229-15237 (2005).
180. Bano, D. et al. Cleavage of the plasma membrane Na+-Ca2+ exchanger in excitotoxicity. Cell 120, 275-285 (2005). This study demonstrated for the first time that the Na+-Ca2+ exchanger (NCX) is cleaved during brain ischaemia in vivo, and in neurons undergoing excitotoxicity in vitro. The overexpression of calpastatin and the expression of a cleavage-resistant NCX isoform resulted in cytoprotection in vitro, suggesting that calpains contribute to the spreading of the excitotoxicitydependent wave of neuronal cell death.
181. Bano, D. et al. The plasma membrane Na+/Ca2+ exchanger is cleaved by distinct protease families in neuronal cell death. Ann. NY Acad. Sci. 1099, 451-455 (2007).
182. Rami, A. Ischemic neuronal death in the rat hippocampus: the calpain-calpastatin-caspase hypothesis. Neurobiol. Dis. 13, 75-88 (2003).
183. Benchoua, A., Braudeau, J., Reis, A., Couriaud, C. & Onteniente, B. Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 24, 1272-1279 (2004).
184. Yamashima, T. et al. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur. J. Neurosci. 10, 1723-1733 (1998).
185. Yamashima, T. Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 36, 285-293 (2004).
186. Chaitanya, G. V. & Babu, P. P. Activation of calpain, cathepsin-b and caspase-3 during transient focal cerebral ischemia in rat model. Neurochem. Res. 33, 2178-2186 (2008).
187. Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).